Psychiatry genetic

Leader

Co-Leaders

Research center

8 rue du général Sarrail
94011 Créteil
Jorge Boczkowski

Institution

Inserm
Université Paris-Est Créteil

Laboratory

U955

Mots clefs

Depression
Schizophrénie
autisme
psychiatrie
biologie moléculaire
imagerie
Stress
Psychose
Bipolaire
Available to host a PhD student

publications

 

Houenou J, Boisgontier J, Henrion A, d'Albis MA, Dumaine A, Linke J, Wessa M, Daban C, Hamdani N, Delavest M, Llorca PM, Lançon C, Schürhoff F, Szöke A, Le Corvoisier P, Barau C, Poupon C, Etain B, Leboyer M, Jamain S. A multi-level functional study of a SNAP25 at-risk variant for bipolar disorder and schizophrenia. J Neurosci. in press. 

Leboyer M, Berk M, Yolken RH, Tamouza R, Kupfer D, Groc L. Immuno-psychiatry: an agenda for clinical practice and innovative research. 2016. BMC Med, 14: 173. 

Pignon B, Schürhoff F, Baudin G, Ferchiou A, Richard JR, Saba G, Leboyer M, Kirkbride JB, Szöke A.  Spatial distribution of psychotic disorders in an urban area of France: an ecological study. 2016. Sci Rep, 6: 26190.

Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N, Herzog E, Bolte S, Prado VF, Prado MA, Bellivier F, Eap CB, Crettol S, Vanhoutte P, Caboche J, Gratton A, Moquin L, Giros B, Maldonado R, Daumas S, Mameli M, Jamain S, El Mestikawy S. The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens. 2015. Mol Psychiatry, 20: 1448-59.

Sarrazin S, Poupon C, Linke J, Wessa M, Phillips M, Delavest M, Versace A, Almeida J, Guevara P, Duclap D, Duchesnay E, Mangin JF, Le Dudal K, Daban C, Hamdani N, D'Albis MA, Leboyer M, Houenou J. A multicenter tractography study of deep white matter tracts in bipolar I disorder: psychotic features and interhemispheric disconnectivity. 2014. JAMA Psychiatry, 71: 388-96.

Fields of research

Neurological and psychiatric diseases

Research Theme

Our research efforts have contributed to a better identification of relevant phenotype for genetic studies, particularly on the field of bipolar disorder, schizophrenia, suicide, autism, OCD and pharmaco-genetic studies. Being principal investigator of national and international groups, she has been able to produce prominent findings such as identification in autism of the first mutations in neuroligins (NLGN-3 and NLGN-4). On top of classical linkage and association studies, her main research contributions have been to more precisely identify relevant phenotypes for psychiatric genetic using two strategies : 1) "candidate symptom" identification among affected subjects allowing the identification of homogenous and more genetic subforms such as early onset bipolar disorder and 2) clinical, biochemical, cognitive and electrophysiological "endophenotypes" among non-affected relatives.